Critical care for prevention of deep-vein thrombosis and its psychoneurotic effects on patients
Not Applicable
- Conditions
- patients with esophageal cancer in the intensive-care unit.
- Registration Number
- JPRN-UMIN000011722
- Lead Sponsor
- Yamaguchi University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Not provided
Exclusion Criteria
Patient with a history of DVT Patient with lost, wounded, or paralyzed right lower leg Patient with estrogen treatment Patient with heparin/warfarin treatment Patient with coagulation defect (Antithrombin Deficiency, Protein C Deficiency, Protein S Deficiency, and Anti-phospholipid antibody syndrome)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measuring femoral venous blood flow 4 times: 0, 5, 15, and 30 minutes after the initiation of intervention.
- Secondary Outcome Measures
Name Time Method